Moreover, the overexpression of N-myc proto-oncogene protein (NMYC) was detected for different tumor types, most notably for cancers of neural and neuroendocrine origin [21], making the MYC-family a highly promising therapeutic target. Here, MYCN is linked to neoplasm.